A Comparative Multi-QSAR Modelling and Molecular Docking Studies of Some Arylsulfonamide-Based ADAM17 Inhibitors as Anticancer Agents

Posted: 10 Feb 2020

See all articles by Sandip Kumar Baidya

Sandip Kumar Baidya

Jadavpur University - Pharmaceutics Research Laboratory

SK Abdul Amin

Jadavpur University, Kolkata

Suvankar Banerjee

Jadavpur University - Department of Pharmaceutical Technology

Tarun Jha

Jadavpur University - Department of Pharmaceutical Technology

Date Written: February 7, 2020

Abstract

Objective: ADAM17 is a zinc-dependent enzyme which is found to execute crucial roles in many threatening diseases such as inflammatory diseases, cancer, Alzheimer's disease and rheumatoid arthritis. Small molecule ADAM17 inhibitors may be valuable weapons in the wrestling against diseases.

Methods: A multi-QSAR modelling studies including 2D-QSAR, HQSAR, Bayesian classification, pharmacophore mapping and molecular docking studies of some arylsulfonamides were performed to explore the structural and pharmacophoric requirements of ADAM17 inhibitors.

Results: All these molecular modelling approaches were validated individually and these were statistically significant and reliable. Some pivotal structural and physicochemical molecular fingerprints that regulate ADAM17 inhibitory activity were identified. Moreover, the bulky steric and hydrophobic P1' substituents at the para position of the arylsulfonamido moiety favoured ADAM17 inhibition that supported and validated by molecular docking study. These crucial observations of arylsulfonamides may be considered for designing higher effective ADAM17 inhibitors in future.

Conclusions: These crucial observations of arylsulfonamides may be considered for designing higher effective ADAM17 inhibitors in future.

Keywords: Cancer, ADAM inhibitor, QSAR, arylsulfonamides, classification model, molecular docking

Suggested Citation

Baidya, Sandip Kumar and Amin, SK Abdul and Banerjee, Suvankar and Jha, Tarun, A Comparative Multi-QSAR Modelling and Molecular Docking Studies of Some Arylsulfonamide-Based ADAM17 Inhibitors as Anticancer Agents (February 7, 2020). Proceedings of International Conference on Drug Discovery (ICDD) 2020, Available at SSRN: https://ssrn.com/abstract=3533717

Sandip Kumar Baidya (Contact Author)

Jadavpur University - Pharmaceutics Research Laboratory ( email )

India
9163673063 (Phone)

SK Abdul Amin

Jadavpur University, Kolkata ( email )

Department of Pharmaceutical Technology, Jadavpur
Kolkata, WEST BENGAL 700032
India
+91-9735801725 (Phone)

HOME PAGE: http://https://www.researchgate.net/profile/Sk_Abdul_Amin

Suvankar Banerjee

Jadavpur University - Department of Pharmaceutical Technology ( email )

India
+91-7278824784 (Phone)

Tarun Jha

Jadavpur University - Department of Pharmaceutical Technology ( email )

India
9433187443 (Phone)

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
116
PlumX Metrics